Dear Reader,
We have identified several healthtech stocks which are expected to go “Ex-Dividend” starting Feb 10th, 2023.
If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Bio-Techne
Symbol: TECH
Recent TECH Stock Price: $78.44
Average Analyst Price Target: $102.80 (31.06%)
TECH Market Cap: $12.43B
Expected Ex-Dividend Date for TECH stock: Feb 10 2023
Expected Payment Date for TECH stock: Feb 27 2023
Expected Dividend & Yield for TECH stock: 0.40%
Recent Analyst Action: Conor McNamara, analyst at RBC Capital, reiterates coverage on Bio-Techne (TECH) stock in the Healthcare sector with a Hold rating and a price target of $ 88 (1 day ago).
TipRanks.com also reports that Bio-Techne stock currently has 11 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $102.80 . The target pricing ranges from a high forecast of $120.00 down to a low forecast of $88.00. Bio-Techne (TECH)’s last closing stock price was $78.44 which would put the average price target at 31.06% upside.Here are 3rd party ratings for TECH stock:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Sell, Top 37% (92 out of 250)
--------------------------------------------------------------------------
Iradimed
Symbol: IRMD
Recent IRMD Stock Price: $37.35
Average Analyst Price Target: $49.50 (32.53%)
IRMD Market Cap: $518.49M
Expected Ex-Dividend Date for IRMD stock: Feb 10 2023
Expected Payment Date for IRMD stock: Feb 21 2023
Expected Dividend & Yield for IRMD stock:
Recent Analyst Action: Scott Henry, analyst at Roth Capital, reiterates coverage on Iradimed (IRMD) stock in the Healthcare sector with a Buy rating and a price target of $ 48 (1 day ago).
TipRanks.com also reports that Iradimed stock currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $49.50 . The target pricing ranges from a high forecast of $51.00 down to a low forecast of $48.00. Iradimed (IRMD)’s last closing stock price was $37.35 which would put the average price target at 32.53% upside.Here are 3rd party ratings for IRMD stock:
- TipRanks.com: Moderate Buy
- TradingView.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Strong Buy, Top 32% (80 out of 250)
--------------------------------------------------------------------------
And there you have it...
Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Sincerely,
The Editor, HealthTechMovers.com
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
